Propedix, an innovator in anti-infective topical dermatology treatments, announces the launch of Dryello (tolnaftate 1%), a breakthrough over-the-counter antifungal treatment for Athlete’s Foot (tinea pedis). Dryello’s unique formulation, delivery approach, and application offer an entirely new way to treat and prevent Athlete’s Foot —with a proprietary dry stick format that goes on dry and stays dry. The Dryello formulation is the first of numerous anti-infective products to emerge from Propedix’s Stick-based DryStik Technology Platform.
Unlike traditional antifungal creams, sprays, and powders, Dryello features a clean, no-mess stick that delivers tolnaftate 1%, a proven antifungal active ingredient, in a portable, dry, deodorant-stick-like format. This first-of-its-kind innovative topical administration system is the first commercial product emerging from Propedix DryStik Technology Platform. A unique and proprietary set of formulations designed to effectively deliver anti-fungal agents through an easy to administer dry applicator glide-on stick. Dryello eliminates the mess of traditional, old-school treatments and allows for delivery of the active agent in a patient-compliant manner. In the company’s recent clinical study, 90% of patients who used Dryello were cured of Athlete’s Foot, and 89% also reported less sweaty feet.
Dryello was designed by board-certified dermatologist Dr. Carl Schanbacher and the R&D team at Propedix after years of development. “Dryello is redefining how we treat Athlete’s Foot,” said Dr. Schanbacher, CMO of Propedix. “Most antifungals add moisture, which can undermine treatment. Dryello applies dry, stays dry, and delivers powerful dual-action relief—treatment and prevention – all in a convenient stick.” The Tinea pedis condition affects nearly one in four people worldwide. Despite this high prevalence, there have been no novel Rx or OTC innovations in multiple decades. “We wanted to create a treatment that wouldn’t just fix the itch, but help people feel confident in their bare feet again,” said Dr. Schanbacher.
Powerful Clinically Tested Results for Athlete’s Foot Relief
In a recent clinical study, patients who used Dryello’s dry stick formulation demonstrated strong efficacy:
- 90% of patients were cured of Athlete’s Foot within 4 weeks
- 89% reported less sweaty feet
Study: Clinical Study to Assess Tolnaftate 1% with a Novel Vehicle for the Treatment of Tinea Pedis, May 2025
Dryello is the first of many anti-infective products that comprise the Propedix pipeline. “Propedix and our R&D team have spent years developing the stick as a DryStik Technology Platform to create formulations and applicator technologies that enhance delivery of safe and effective existing anti-pathogenic agents,” said Niv Caviar, CEO of Propedix. “The proprietary nature of our science, clinical results and supporting patents will help establish Propedix as a leader in novel dermatological treatments for skin disorders and antifungal infections.”
Read Similar news:
XRP Healthcare Upgrades its Digital Health App
